Medtronic Other Noncash Income (Expense) increased by 46.3% to -$159.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric declined by 1866.7%, from $9.00M to -$159.00M. Over 2 years (FY 2021 to FY 2024), Other Noncash Income (Expense) shows a downward trend with a 51.1% CAGR.
other_other_noncash_income_expense| Q4 '21 | Q1 '22 | Q2 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$90.00M | -$116.00M | -$32.00M | -$46.00M | -$121.00M | -$61.00M | $0.00 | -$88.00M | -$135.00M | $233.00M | -$363.00M | -$308.00M | $9.00M | -$176.00M | -$296.00M | -$159.00M |
| QoQ Change | — | -28.9% | +72.4% | -43.8% | -163.0% | +49.6% | +100.0% | — | -53.4% | +272.6% | -255.8% | +15.2% | +102.9% | <-999% | -68.2% | +46.3% |
| YoY Change | — | — | — | +48.9% | -4.3% | -90.6% | — | -91.3% | -11.6% | +482.0% | — | -250.0% | +106.7% | -175.5% | +3.9% | <-999% |